Healthcare Jan 30, 2023 10:44 AM (GMT+8) · EqualOcean
Levostar (Chinese: 左旋星生物) has raised the second financing round since its founding in 2022, which was led by Matrix Partner (Chinese: 经纬创投). Proceeds will be used to expand the GMP-level production and upgrade safety testing and evaluation platform for CGT products. Levostar is a developer and producer of cell gene therapy products intended to provide breakthrough technologies and full-coverage solutions for the CGT industry. The company's products include its clinical testing services for cell therapy platforms, viral vector platforms, mRNA vaccines and therapeutic platforms, and GMP-level production processes and product quality control methods for plasmids and mRNAs, enabling the biotechnological industry to accelerate the process of gene cell therapy and mRNA drug research and developm